Pubblicazioni

Asciminib monotherapy in patients with CML-CP without BCR::ABL1 T315I mutations treated with at least two prior TKIs: 4-year phase 1 safety and efficacy results

2023 - LEUKEMIA

Mauro, Michael J.; Hughes, Timothy P.; Kim, Dong-Wook; Rea, Delphine; Cortes, Jorge E.; Hochhaus, Andreas; Sasaki, Koji; Breccia, Massimo; Talpaz, Moshe; Ottmann, Oliver; Minami, Hironobu; Goh, Yeow Tee; Deangelo, Daniel J.; Heinrich, Michael C.; Gomez-Garcia de Soria, Valle; le Coutre, Philipp; Mahon, Francois-Xavier; Janssen, Jeroen J. W. M.; Deininger, Michael; Shanmuganathan, Naranie; Geyer, Mark B.; Cacciatore, Silvia; Polydoros, Fotis; Agrawal, Nithya; Hoch, Matthias; Lang, Fabian

Combination of Asciminib, a Novel and Specific BCR-ABL1 Inhibitor, Plus Imatinib in Previously Treated Chronic Myeloid Leukemia (CML) Patients: Phase 1 Study Results

2019 - CLINICAL LYMPHOMA MYELOMA & LEUKEMIA

Talpaz, Moshe; Cortes, Jorge; Lang, Fabian; Kim, Dong-Wook; RÃ©a, Delphine; Mauro, Michael J.; Minami, Hironobu; Breccia, Massimo; Deangelo, Daniel J.; Hochhaus, Andreas; Tee Goh, Yeow; Le Coutre, Philipp D.; Sondhi, Manu; Mishra, Kaushal; Hourcade-Potelleret, Florence; Vanasse, Gary; Aimone, Paola; Hughes, Timothy P.

Transcriptional activation of the miR-17-92 cluster is involved in the growth-promoting effects of MYB in human Ph-positive leukemia cells

2018 - HAEMATOLOGICA

Spagnuolo, Manuela; Regazzo, Giulia; De Dominici, Marco; Sacconi, Andrea; Pelosi, Andrea; Korita, Etleva; Marchesi, Francesco; Pisani, Francesco; Magenta, Alessandra; Lulli, Valentina; Cordone, Iole; Mengarelli, Andrea; Strano, Sabrina; Blandino, Giovanni; Rizzo, Maria G; Calabretta, Bruno